Paramedic Papers

Home Cardiac arrest DSED use rising but still low after DOSE VF

Cardiac arrest

DSED use rising but still low after DOSE VF

Use of double sequential external defibrillation in the United States before and after the DOSE VF randomized clinical trial
Prehospital Emergency Care · Added 18 May 2026

Nationwide observational study examined trends in DSED use for refractory VF before and after publication of the DOSE VF trial.

Study type
Cohort
Design
Retrospective interrupted time-series analysis of a national EMS data collaborative
Participants
16,450 adults with OHCA and VF/pVT and ≥4 defibrillation attempts from 906 agencies, 2018–2024
Main finding
DSED use varied by identification method (1.8%–7.6%); use detected by any method increased after DOSE VF publication (7.3% vs 8.2%, p=0.048), with a rate increase of RR 1.09 (95% CI 1.04–1.14) per quarter.
Caveat
DSED identified by proxy measures with potential misclassification; observational design cannot link use to outcomes.
Bottom line
Context only

Learning goal

Weigh the emerging evidence for double sequential defibrillation in refractory ventricular fibrillation cardiac arrest.

Open in dashboard Read the paper (DOI) PubMed

More

Related papers on Cardiac arrest